Concepedia

Raquel Rodríguez-Lorca

RR

Statistics

Publications

4

Citations

113

H-Index

4

Active since

2015

Affiliations

Universitat de les Illes Balears(Current)

Raquel Rodríguez-Lorca is an author at Universitat de les Illes Balears specializing in oncology, cancer cell proliferation inhibition, and pharmacology.

ORCID

Publications per year

2015–2021

4

Publications

4

The Novel Antitumor Compound HCA Promotes Glioma Cell Death by Inducing Endoplasmic Reticulum Stress and Autophagy

Roberto Beteta-Göbel, Javier Fernández-Díaz, Laura Arbona-González et al. · Cancers · 2021 · 45 citations · Full text

, , +17

The Opposing Contribution of SMS1 and SMS2 to Glioma Progression and Their Value in the Therapeutic Response to 2OHOA

Paula Fernández‐García, Catalina Ana Rosselló, Raquel Rodríguez-Lorca et al. · Cancers · 2019 · 31 citations · Full text

, , +16

The triacylglycerol, hydroxytriolein, inhibits triple negative mammary breast cancer cell proliferation through a mechanism dependent on dihydroceramide and Akt

Francisca Guardiola-Serrano, Roberto Beteta-Göbel, Raquel Rodríguez-Lorca et al. · Oncotarget · 2019 · 20 citations · Full text

, , +17

The Novel Anticancer Drug Hydroxytriolein Inhibits Lung Cancer Cell Proliferation via a Protein Kinase Cα– and Extracellular Signal-Regulated Kinase 1/2–Dependent Mechanism

Francisca Guardiola-Serrano, Roberto Beteta-Göbel, Raquel Rodríguez-Lorca et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 17 citations

, , +16

1–4 of 4